Literature DB >> 16960875

Expression profiling of vitamin D treated primary human keratinocytes.

Pamela Renate Moll1, Veronika Sander, Anna-Maria Frischauf, Klaus Richter.   

Abstract

Vitamin D has attracted much attention by its ability to stop cell proliferation and induce differentiation, which became of particular interest for the treatment of cancer and psoriasis. We performed an expression profile of 12 hours and 24 hours 1alpha,25-dihydroxyvitamin D(3) (1alpha,25(OH)(2)D(3)) treated primary human keratinocytes, to determine the changes in gene expression induced by the steroid in order to improve our understanding of the biological activity of 1alpha,25(OH)(2)D(3). This we expect to be useful for establishing a test system for vitamin D analogs or might open new therapeutic targets or uses for the hormone. For the filter array experiments a non-redundant set of 2135 sequence verified EST clones was used. The normalized raw data of 2 filters per time point were combined and subjected to SAM analysis to further increase the statistical significance. 86 positive and 50 negative genes were identified after 12 h. The numbers went down to 43 positive and 1 negative gene after 24 h of treatment. Fifteen genes are up-regulated over a longer period of time (12 h and 24 h). Results were verified by real-time PCR and/or Northern blots. Targets identified are involved in intracellular signaling, transcription, cell cycle, metabolism, cellular growth, constitution of the extracellular matrix or the cytoskeleton and apoptosis, immune responses, and DNA repair, respectively. Expression profiles showed an initial stop of proliferation and induction of differentiation, and resumed proliferation after prolonged incubation, most likely due to degradation of the hormone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16960875     DOI: 10.1002/jcb.21061

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

Review 2.  Protective role of vitamin D signaling in skin cancer formation.

Authors:  Daniel D Bikle; Hashem Elalieh; Joellen Welsh; Dennis Oh; James Cleaver; Arnaud Teichert
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

Review 3.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

Review 4.  Protective actions of vitamin D in UVB induced skin cancer.

Authors:  Daniel D Bikle
Journal:  Photochem Photobiol Sci       Date:  2012-12       Impact factor: 3.982

Review 5.  Vitamin D in cutaneous carcinogenesis: part II.

Authors:  Jean Y Tang; Teresa Fu; Christopher Lau; Dennis H Oh; Daniel D Bikle; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

Review 6.  Vitamin D in cutaneous carcinogenesis: part I.

Authors:  Jean Y Tang; Teresa Fu; Christopher Lau; Dennis H Oh; Daniel D Bikle; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

7.  The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin.

Authors:  Blake C Ellis; Sebastiano Gattoni-Celli; Annalaura Mancia; Mark S Kindy
Journal:  Dev Comp Immunol       Date:  2009-03-21       Impact factor: 3.636

Review 8.  Vitamin D receptor, a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Can J Physiol Pharmacol       Date:  2014-12-08       Impact factor: 2.273

Review 9.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 10.  Vitamin D and death by sunshine.

Authors:  Katie M Dixon; Wannit Tongkao-On; Vanessa B Sequeira; Sally E Carter; Eric J Song; Mark S Rybchyn; Clare Gordon-Thomson; Rebecca S Mason
Journal:  Int J Mol Sci       Date:  2013-01-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.